The thiazide-sensitive Na+-CI- cotransporter gene, C1784T, and adrenergic receptor-β3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics

Hypertension Research

Volumn 27, Issue 11, 2004, Pages 821-833

  Matayoshi, Tetsutaro ^a   Kamide, Kei ^a   Takiuchi, Shin ^a   Yoshii, Masayoshi ^a   Miwa, Yoshikazu ^a   Takami, Yoichi ^a   Tanaka, Chihiro ^a   Banno, Mariko ^a   Horio, Takeshi ^a   Nakamura, Satoko ^a   Nakahama, Hajime ^a   Yoshihara, Fumiki ^a   Inenaga, Takashi ^a   Miyata, Toshiyuki ^a   Kawano, Yuhei ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Essential hypertension; Gene polymorphism; Thiazide diuretics

Indexed keywords

ADRENERGIC RECEPTOR; ALDOSTERONE SYNTHASE; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; COTRANSPORTER; HYDROCHLOROTHIAZIDE; INDAPAMIDE; MEFRUSIDE; THIAZIDE DIURETIC AGENT; TRICHLORMETHIAZIDE;

ADULT; AGED; ALLELE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD SAMPLING; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG SENSITIVITY; ELECTROLYTE BALANCE; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT; PREDICTION; PREVALENCE; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

BENZOTHIADIAZINES; CALMODULIN-BINDING PROTEINS; DIURETICS; DRUG RESISTANCE; FEMALE; HAPLOTYPES; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; HYPERTENSION, RENAL; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ADRENERGIC, BETA-3; RECEPTORS, DRUG; RECEPTORS, MINERALOCORTICOID; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES; SODIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM CHLORIDE SYMPORTERS; SODIUM-CALCIUM EXCHANGER; SYMPATHETIC NERVOUS SYSTEM; SYMPORTERS; VARIATION (GENETICS);

EID: 20044393289     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.821     Document Type: Article

References (41)

1. Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report. JAMA 2003; 289: 2560-2572.
2. Guideline Subcommittee: 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
3. The ALLHAT Officers and Coordinators for ALLHAT Collaborative Research Group: Major outcomes in highrisk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002; 288: 2981-2997.
4. Kaplan NM: Clinical Hypertension. Treatment of Hypertension: Drug Therapy, 8th ed. Philadelphia, Lippincott Williams & Wilkins, 2002.
5. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E: C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001; 37: 739-743.
6. Glorioso N, Manunta P, Filigheddu F, et al: The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 1999; 34: 649-654.
7. Sugimoto K, Hozawa A, Katsuya T, et al: Alpha-adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the ohasama study. J Hypertens 2002; 20: 1779-1784.
8. Gitelman HJ, Graham JB, Welt LG: A new familial disorder characterized by hypokalemia and hypomagenesemia. Trans Assoc Am Physicians 1966; 79: 221-235.
9. Simon DB, Nelson WC, Bia MJ, et al: Gitleman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotrasporter. Nat Genet 1996; 12: 24-30.
10. Wilson FH, Disse-Nicodeme S, Choate KA, et al: Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112.
11. Geller DS, Rodriguez-Soriano J, Vallo Boado A, et al: Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 1998; 19: 279-281.
12. 2+ exchanger from the Dahl/Rapp salt sensitive rat to regulate cytosolic calcium. Am J Physiol Renal Physiol 2003; 284 F1023-F1031.
13. Okuda T, Fujioka Y, Kamide K, et al: Verification of 525 coding SNPs in 179 hypertension candidate genes in the Japanese population: identification of 159 SNPs in 93 genes. J Hum Genet 2002; 47: 387-394.
14. Siffert W, Rosskopf D, Siffert G, et al: Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18: 45-48.
15. Nakajima T, Jorde LB, Ishigami T, et al: Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet 2002; 70: 108-123.
16. Hilger KF, Delles C, Veelken R, Schmieder RE: Angiotensionogen gene core promoter variants and non-modulating hypertension. Hypertension 2001; 38: 1250-1254.
17. Tanaka C, Kamide K, Takiuchi S, et al: An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003; 26: 301-306.
18. Bonnardeaux A, Davies E, Jeunemaitre X, et al: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24: 63-69.
19. Lajemi M, Labat C, Gautier S, et al: Angiotensin II type 1 receptor - 153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001; 19: 407-413.
20. Kupari M, Hautanen A, Lankinen L, et al: Association between human aldosterone synthase (CYP11B2) gene polymorphisms and left venyricular size, mass, and function. Circulation 1998; 97: 569-575.
21. Bengtsson K, Melander O, Orho-Melander M, et al: Polymorphism in β1-adrenergic receptor gene and hypertension. Circulation 2001; 104: 187-190.
22. Bengtsson K, Orho-Melander M, Melander O, et al: Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 2001; 37: 1303-1308.
23. Ranade K, Jorgenson E, Sheu W H-H, et al: A polymorphism in β1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002; 70: 935-942.
24. Tonolo G, Melis MG, Secchi G, et al: Association of Trp64Arg beta 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J Hypertens 1999; 17 33-38.
25. Shibata K, Hirasawa A, Moriyama N, Kawabe K, Ogawa S, Tsujimoto G: α1a-Adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br J Pharmacol 1996; 118: 1403-1408.
26. Buscher R, Herrmann V, Ring KM, et al: Variability in phenylephrine response and essential hypertension: a search for human α1B-adrenergic receptor polymorphisms. J Pharmacol Exp Ther 1999; 291: 793-798.
27. Michel MC, Plogmann C, Philipp T, Brodde O-E: Functional correlates of α2a-adrenocetor gene polymorphism in the HANE study. Nephrol Dial Transplant 1999; 14: 2657-2663.
28. Ardlie KG, Kruglyak L, Seielstad M: Patterns of linkage disequilibrium in the human genome. Nat Rev 2002; 3: 299-309.
29. Cruz DN, Simon DB, Nelson-Williams C, et al: Mutations in the Na-Cl contransporter reduce blood pressure in humans. Hypertension 2001; 37: 1458-1464.
30. Melander O, Orho-Melander M, Bengtsson K, et al: Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension. Hypertension 2000; 36: 389-394.
31. Wilson FH, Kahle KT, Sabath E, et al: Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A 2003; 100: 680-684.
32. Yang CL, Angell J, Mitchell R, Ellison DH: WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 2003; 111: 1039-1045.
33. Garbers DL, Dubosis SK: The molecular basis of hypertension. Annu Rev Biochem 1999; 68: 127-155.
34. Sciarrone MT, Stella P, Barlassina C, et al: ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 2003; 41: 398-403.
35. Intersalt Cooperative Research Group: Intersalt: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. Br Med J 1988; 297: 319-328.
36. Clement K, Vaisse C, Manning BSJ, et al: Genetic variation in the beta-3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New Engl J Med 1995; 333: 352-354.
37. Urhammer SA, Hansen T, Borch-Johnsen K, Pedersen O: Studies of the synergistic effect of the trp/arg64 polymorphism of the beta-3-adrenergic receptor gene and the - 3826 A-G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 young Danish subjects. J Clin Endocrinol Metab 2000; 85: 3151-3154.
38. Elbein SC, Hoffman M, Barrett K, et al: Role of the beta-3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab 1996; 81: 4422-4427.
39. Fujisawa T, Ikegami H, Yamato E, et al: Trp64Arg mutation of 3-adrenergic receptor in essential hypertension; insulin resistance and the adrenergic system. Am J Hypertens 1997; 10 101-105.
40. Rissanen J, Kuopusjari J, Pihlajamaki J, et al: The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene: lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 1997; 20: 1319-1323.
41. Shihara N, Yasuda K, Moritani T, et al: The association between Trp64Arg polymorphism of the beta 3-adrenergic receptor and autonomic nervous system activity. J Clin Endocrinol Metab 1999; 84: 1623-1627.